Renin-Angiotensin system blockers may prolong survival of metastatic non-small cell lung cancer patients receiving erlotinib.
about
Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studiesTargeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.[Advance in Research of Angiotensin II and Its Receptor and Malignant Tumor].
P2860
Renin-Angiotensin system blockers may prolong survival of metastatic non-small cell lung cancer patients receiving erlotinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Renin-Angiotensin system block ...... patients receiving erlotinib.
@ast
Renin-Angiotensin system block ...... patients receiving erlotinib.
@en
type
label
Renin-Angiotensin system block ...... patients receiving erlotinib.
@ast
Renin-Angiotensin system block ...... patients receiving erlotinib.
@en
prefLabel
Renin-Angiotensin system block ...... patients receiving erlotinib.
@ast
Renin-Angiotensin system block ...... patients receiving erlotinib.
@en
P2093
P2860
P1433
P1476
Renin-Angiotensin system block ...... patients receiving erlotinib.
@en
P2093
Adnan Aydiner
Rumeysa Ciftci
P2860
P356
10.1097/MD.0000000000000887
P407
P577
2015-06-01T00:00:00Z